62 related articles for article (PubMed ID: 23146656)
21. Polymyalgia rheumatica and giant cell arteritis.
Unwin B; Williams CM; Gilliland W
Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
[TBL] [Abstract][Full Text] [Related]
22. Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica.
Straub RH; Cutolo M
J Rheumatol; 2006 Jul; 33(7):1219-23. PubMed ID: 16821261
[No Abstract] [Full Text] [Related]
23. [Glucocorticoid treatment improves glucose tolerance in patients with temporal arteritis or polymyalgia rheumatica].
Sáez Barcelona JA; Carmona Martín M; Navarro López V; Blanch Sancho JJ; Puras Tellaeche A
Rev Clin Esp; 1999 May; 199(5):270-4. PubMed ID: 10396146
[TBL] [Abstract][Full Text] [Related]
24. Acute stress-induced sensitization of the pituitary-adrenal response to heterotypic stressors: independence of glucocorticoid release and activation of CRH1 receptors.
Belda X; Daviu N; Nadal R; Armario A
Horm Behav; 2012 Sep; 62(4):515-24. PubMed ID: 22986335
[TBL] [Abstract][Full Text] [Related]
25. Clinical review: corticotherapy in sepsis.
Prigent H; Maxime V; Annane D
Crit Care; 2004 Apr; 8(2):122-9. PubMed ID: 15025773
[TBL] [Abstract][Full Text] [Related]
26. [Steroid therapy and adrenal function].
Cota D; Ceroni L; Pasquali R
Recenti Prog Med; 2000 Nov; 91(11):594-600. PubMed ID: 11125954
[TBL] [Abstract][Full Text] [Related]
27. [Polymyalgia rheumatica and giant-cell temporal arteritis].
Tereshchenko IV
Klin Med (Mosk); 2006; 84(8):25-30. PubMed ID: 17087187
[TBL] [Abstract][Full Text] [Related]
28. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice.
Heydendael W; Jacobson L
Eur J Neurosci; 2010 Mar; 31(5):892-902. PubMed ID: 20374287
[TBL] [Abstract][Full Text] [Related]
29. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
Buckley TM; Mullen BC; Schatzberg AF
Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
[TBL] [Abstract][Full Text] [Related]
30. Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
Spigset O; Mjörndal T
Psychopharmacology (Berl); 1997 Sep; 133(1):39-42. PubMed ID: 9335078
[TBL] [Abstract][Full Text] [Related]
31. Treatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone.
Dasgupta B; Gray J; Fernandes L; Olliff C
Ann Rheum Dis; 1991 Dec; 50(12):942-5. PubMed ID: 1768166
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid-resistance in peripheral-blood lymphocytes does not correlate with number of affinity of glucocorticoid-receptors in chronic renal failure patients.
Hirano T; Horigome A; Oka K; Takeuchi H; Yoshida M; Sakurai E; Kozaki K; Matsuno N; Nagao T; Kozaki M
Immunopharmacology; 1997 Apr; 36(1):57-67. PubMed ID: 9129997
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids and natural killer cells: A suppressive relationship.
Muscari I; Fierabracci A; Adorisio S; Moretti M; Cannarile L; Thi Minh Hong V; Ayroldi E; Delfino DV
Biochem Pharmacol; 2022 Apr; 198():114930. PubMed ID: 35149054
[TBL] [Abstract][Full Text] [Related]
34. Methodological considerations for the human platelet 5-HT2A receptor binding kinetic assay.
Khait VD; Huang YY; Mann JJ
Life Sci; 1999; 65(24):2615-22. PubMed ID: 10619369
[TBL] [Abstract][Full Text] [Related]
35. Recent Studies on Serotonin 5-HT
Kamadar JH; Kumari DR; Kapadiya KM
Mini Rev Med Chem; 2023; 23(19):1859-1870. PubMed ID: 37157202
[TBL] [Abstract][Full Text] [Related]
36. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
Stenman UH
Scand J Clin Lab Invest; 2004; 64(1):1-2. PubMed ID: 15025422
[No Abstract] [Full Text] [Related]
37. [Spondylocalcinosis and its treatment].
de PAULA A
Rev Bras Med; 1951 Feb; 8(2):105-11. PubMed ID: 14834527
[No Abstract] [Full Text] [Related]
38. Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia.
Ma S; Li T; Guo K; Li X; An S; Hou S; Chen R; Yang B; Liu S; Fu J
J Diabetes Investig; 2016 Nov; 7(6):833-844. PubMed ID: 27177506
[TBL] [Abstract][Full Text] [Related]
39. Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver.
Fu J; Ma S; Li X; An S; Li T; Guo K; Lin M; Qu W; Wang S; Dong X; Han X; Fu T; Huang X; Wang T; He S
Int J Biol Sci; 2016; 12(2):219-34. PubMed ID: 26884719
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid treatment increases density of serotonin 5-HT2A receptors in humans.
Kling A; Mjörndal T; Rantapää-Dahlqvist S
Psychoneuroendocrinology; 2013 Jul; 38(7):1014-20. PubMed ID: 23146656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
